Asaad Trabolsi

10PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 23, 2026
Response to: "Refining Combined-Modality Therapy and Charting the Future of Primary Vitreoretinal Lymphoma".

|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

|Mar 20, 2026
Predictors and timing of venous thromboembolism and overall survival in lymphoma.

Asaad Trabolsi, Thomas E Plate, Tessa Lavorgna

|Jun 21, 2025
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study.

Frederique St-Pierre, Subodh Bhatta, Peter G Doukas

|Jul 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.

Dan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi

|Apr 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.

Samuel A Kareff, Asaad Trabolsi, Harris B Krause

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan H Schatz

3 joint publications

Izidore S Lossos

2 joint publications

Artavazd Arumov

2 joint publications

Estelamari Rodriguez